Manali Petrochemicals LtdQ2 FY25
Manali Petrochemicals Ltd Q2 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹80.2P/E: 12.3Market Cap: ₹1.5K CrSector: Chemicals & Petrochemicals
Management growth scorecard
Revenue
Category 3
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 2 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- The company expects growth in revenue and volumes, particularly driven by capacity expansions in Propylene Glycol (PG) and polyester polyols.
- PG capacity expansion of 32,000 MT (Q2 FY 2025 completion) will cater primarily to food, beverage, and pharmaceutical sectors with phased volume ramp-up.
- Polyester polyol expansion (8,000 MT second phase expected by Q3/Q4 FY 2025) targets construction, appliances, and elastomers markets.
- A new Greenfield plant in Western India planned for 30,000 MT annually of polyols, with a projected IRR of 30% and five-year payback, focusing on local market demand.
- PennWhite aims for up to 10% share of the Indian foam control market (premium segment), with local manufacturing considered key for growth.
- The company aims to surpass pre-COVID revenue levels through organic growth and market expansion in India, Europe, and emerging regions.
- Focus remains on premium, specialty products with higher margins rather than commodity products, with moderate capacity utilization (~50-60%).
See what Manali Petrochemicals Ltd management said on margin guidance — free account, 30 seconds.
Fundraise plans
- No specific mention of any current or future fundraising through debt or equity in the provided transcript.
- The company highlights a strong liquidity position, with around INR 400 crores available by end of June 2024.
- Long-term debt is very low; expansions are funded predominantly through internal accruals.
- Investment projects like the propylene glycol plant, polyester polyol plants, and West India Greenfield expansion are largely financed through internal accruals and existing liquidity with a balanced debt-equity ratio (e.g., 50:50 for PG plant).
- No explicit discussion or announcement on plans for raising new debt or issuing equity was made in the Q&A or management remarks.
See what Manali Petrochemicals Ltd management said on order book — free account, 30 seconds.
Capex plans
Yes- A 30,000 MT per annum polyols expansion project in Western India has been approved with an investment of INR 130+ crores, targeting an IRR of 30% and a five-year payback; currently in preliminary stages with more details expected after a quarter.
- Investment focus on sustainability initiatives including carbon reduction projects like adopting Econic catalyst technology and ZLD (Zero Liquid Discharge) with feasibility studies underway before Board approval.
- PennWhite subsidiary operates at ~50% utilization after debottlenecking; growth plans are ambitious but no major CapEx expected in the next 3-5 years; expansion will be driven by increased staffing rather than capital investment.
- Internal accruals primarily fund expansions with expected IRRs of 20% (PG expansion), 23% (polyester polyol), and 30% (Western India Greenfield).
- Moves toward green energy with 68% renewable power usage, R-LNG adoption to phase out furnace oil, and installations like solar panels at Notedome to reduce carbon footprint and costs.
Track Manali Petrochemicals Ltd — get its next earnings analysis in your feed
Margin guidance
- The company expects FY 2025 to be an inflection point with a revival in profitability compared to historically low spreads in FY 2023-24.
- Capacity expansions (propylene glycol +32,000 MT; polyester polyols expansion ongoing) are expected to start contributing volumes and revenues from Q2 FY 2025, driving top-line growth.
- Utilization levels for subsidiaries (Notedome and PennWhite) are around 50-60%, with room to grow without major CapEx; PennWhite anticipates no major CapEx for 3-5 years due to existing free capacity.
- EBITDA and margins are expected to improve as capacity ramps up, but detailed guidance on earnings, margins, and EPS over 2-3 years is not provided due to UPSI regulations.
- Focus remains on specialty products with premium pricing to sustain margins and customer stickiness.
- New Western India polyol plant (30,000 MT) project is in early stages, targeting a 30% IRR with a 5-year payback, indicating long-term margin improvement potential.
- The company is cautiously optimistic about sustainable growth supported by government anti-dumping duties and market conditions.
Order book
The transcript does not explicitly mention the current or expected order book or pending orders for Manali Petrochemicals Limited or its subsidiaries. However, some relevant insights related to growth and demand include:
- PennWhite expects to capture up to 10% of the Indian foam control chemistry market long-term, with current exports to India modest.
- The company's growth plans focus on premium specialty segments rather than commodity volumes.
- Expansion projects in Western India targeting 30,000 MT system polyols and a 32,000 MT propylene glycol plant indicate preparation for increased demand.
- Capacity utilizations are currently moderate (~50-60%), with plans to grow organically before significant new CapEx.
- Management highlights a positive long-term outlook, but does not provide specific current order book or backlog figures in the call.
Hence, no direct data on exact order book or pending orders is disclosed.
How does Manali Petrochemicals Ltd rank vs peers in Chemicals & Petrochemicals?
Pro featureThisManali Petrochemicals Ltd
Rev 3
How does Manali Petrochemicals Ltd rank in Chemicals & Petrochemicals?
Compare Manali Petrochemicals Ltd against every Chemicals & Petrochemicals company (Q2 FY25) on revenue, margins and earnings-call signals.
Continue your research
What Manali Petrochemicals Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Sudarshan Chemical Industries Ltd (Q1 FY27)
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
- Indo Borax & Ch. (Q1 FY27)
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
- SRF Ltd (Q1 FY27)
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…
- Deepak Fertilis. (Q1 FY27)
Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions. Key concall takeaways from…